查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1756491

RSV 诊断市场（按产品、按方法、按最终用户、按国家和地区）- 2024 年至 2032 年行业分析、市场规模、市场份额及预测

RSV Diagnostics Market, By Product, By Method, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年 RSV 诊断市场规模价值为 6,4566.7 亿美元，2024 年至 2032 年的复合年增长率为 5.87%。

呼吸道合胞病毒 (RSV) 诊断市场-市场动态

呼吸道感染盛行率不断上升

呼吸道感染发生率的上升，尤其是在婴儿、老年人和免疫功能低下患者群体中，是呼吸道合胞病毒 (RSV) 诊断市场的主要驱动力。呼吸道合胞病毒 (RSV) 是全球下呼吸道感染的主要原因，导致大量住院和医疗费用增加。透过先进的 RSV 诊断工具进行早期准确诊断有助于及时治疗并减少感染传播。此外，医疗保健提供者意识的提高以及诊断技术可近性的提高进一步推动了市场成长。这些因素共同推动了全球对高效快速 RSV 诊断解决方案的需求。

RSV 诊断市场—关键见解

根据我们的研究分析师，全球 RSV 诊断市场预计在 2024 年至 2032 年期间以约 5.87% 的复合年增长率发展。

2024 年按产品细分，试剂盒和检测类别占据了市场主导地位。

根据最终用户，医院和诊所部门在 2024 年创造了最多的收入。

按地区划分，2024年北美是收入最高的地区。

RSV 诊断市场-細項分析：

全球 RSV 诊断市场分为四大类：产品、方法、最终用户和地区。

依产品划分，呼吸道合胞病毒 (RSV) 诊断市场分为试剂盒及检测试剂、仪器及其他产品。试剂盒及检测试剂包括用于检测病患检体中 RSV 抗原或核酸的试剂及检测试剂盒。仪器是指用于进行诊断测试的设备和分析仪，例如 PCR 仪和免疫测定读数仪。其他产品包括测试过程中所需的耗材和配件。在这些细分市场中，试剂盒及检测试剂占据主导地位，因为它们在提供快速且准确的结果方面发挥关键作用，这对于及时的临床决策至关重要。试剂盒的便利性、易用性和检测技术的进步推动了医院、诊所和诊断实验室对试剂盒的广泛采用，使其成为 RSV 诊断市场最大的收入贡献者。

按最终用户划分，呼吸道合胞病毒 (RSV) 诊断市场可细分为医院和诊所、临床实验室和家庭护理。医院和诊所是患者直接接受诊断和治疗的医疗机构，通常处理大量呼吸道病例。临床实验室专门进行诊断检测，配备先进设备和熟练的人员，为多家医疗机构提供服务。居家照护涉及居家检测解决方案，可在传统医疗机构之外提供便利的早期检测服务。其中，医院和诊所因其在患者护理中发挥一线作用而占据市场主导地位，尤其是在呼吸道合胞病毒 (RSV) 疫情高发生季节，呼吸道感染激增。他们需要快速、准确的诊断来控制疫情并立即提供治疗，这推动了对 RSV 诊断产品的巨大需求，使其成为市场上最大、影响力最大的最终用户群。

呼吸道合胞病毒 (RSV) 诊断市场—地理洞察

从地理分布来看，呼吸道合胞病毒 (RSV) 诊断市场分布于北美、亚太地区、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美在呼吸道合胞病毒（RSV）诊断市场占据主导地位，这得益于先进的医疗基础设施、创新诊断技术的广泛应用以及高昂的医疗支出。该地区RSV感染负担沉重，尤其是在婴幼儿和老年人群中，因此对精准快速检测的需求日益增长。此外，强有力的政府支持、完善的报销政策以及领先的市场参与者的存在，也促进了市场的强劲成长。医疗服务提供者和患者对RSV早期诊断重要性的认识不断提高，进一步推动了北美市场的扩张。

亚太地区是呼吸道合胞病毒（RSV）诊断市场的另一个主导地区，其庞大的患者群体和不断上升的呼吸道感染发病率推动了这个市场的发展。快速的城市化、医疗设施的改善以及医疗基础设施投资的增加，促进了RSV诊断解决方案的普及。中国、印度和日本等国家是RSV诊断解决方案的主要贡献者，这得益于政府日益加强的传染病防治措施。此外，城乡地区诊断检测意识的提高和可近性的提升也推动了市场的成长，使亚太地区成为全球RSV诊断领域中关键且快速成长的市场。

RSV 诊断市场-竞争格局：

呼吸道合胞病毒（RSV）诊断市场由专注于提高准确性和快速检测的成熟诊断公司和创新新进入者共同构成​​。雅培、罗氏、赛默飞世尔和碧迪等主要参与者凭藉种类繁多的高品质诊断试剂盒、仪器和检测试剂占据市场主导地位。这些公司在研发方面投入巨资，以提高检测灵敏度、缩短週转时间并符合严格的监管标准。新兴公司正在推出新型分子和即时检测解决方案，加剧了竞争。这种动态促进了持续创新，扩大了RSV诊断在医院、诊所和实验室的应用，从而改善了全球呼吸道感染管理。

最新动态：

2024 年 4 月，雅培推出了针对呼吸道合胞病毒和流感的下一代即时分子检测，可更快、更准确地诊断呼吸道感染，从而支持在不同的临床环境中获得更好的患者治疗结果。

2023 年 6 月，BD 完成了将其手术器械和腹腔镜器械业务出售给 STERIS plc 的交易，从而精简了其产品组合，专注于核心诊断和医疗设备领域。

目录

第 1 章：呼吸道合胞病毒诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • RSV 诊断市场（按产品）摘要
    • 呼吸道合胞病毒 (RSV) 诊断市场片段（依方法）
    • RSV 诊断市场片段（按最终用户）
    • 呼吸道合胞病毒 (RSV) 诊断市场（按国家/地区）
    • 呼吸道合胞病毒 (RSV) 诊断市场（按地区）
  • 竞争洞察

第 3 章：呼吸道合胞病毒诊断关键市场趋势

  • 呼吸道合胞病毒诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 呼吸道合胞病毒诊断市场限制
    • 市场限制的影响分析
  • 呼吸道合胞病毒诊断市场机会
  • 呼吸道合胞病毒诊断市场未来趋势

第四章：呼吸道合胞病毒诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：呼吸道合胞病毒诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：呼吸道合胞病毒诊断市场格局

  • 2023 年呼吸道合胞病毒 (RSV) 诊断市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：呼吸道合胞病毒诊断市场 - 按产品

  • 概述
    • 按产品细分的市占率分析
    • 试剂盒和检测试剂
    • 仪器
    • 其他产品

第 8 章：呼吸道合胞病毒 (RSV) 诊断市场 - 依方法

  • 概述
    • 依方法细分市场占有率分析
    • 分子诊断
    • 快速抗原检测
      • 酵素连结免疫吸附试验
      • 免疫萤光试验
      • 其他快速抗原检测
      • 色谱免疫分析
      • 光学免疫分析
    • 其他方法

第 9 章：呼吸道合胞病毒诊断市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和诊所
    • 临床实验室
    • 居家护理

第 10 章：呼吸道合胞病毒 (RSV) 诊断市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美呼吸道合胞病毒诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模和预测（按方法）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲呼吸道合胞病毒诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模与预测（按方法）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区呼吸道合胞病毒诊断主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按产品）
    • 亚太市场规模及预测（依方法）
    • 亚太市场规模及预测（依最终用户）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲呼吸道合胞病毒诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模与预测（按方法）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲呼吸道合胞病毒诊断主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模和预测（按方法）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：RSV 诊断产业关键供应商分析

  • 竞争仪錶板
  • 公司简介
    • Biomerieux
    • Becton, Dickinson and Company (BD)
    • Abbott
    • Roche
    • Danaher
    • Thermo Fisher
    • Biocartis
    • Luminex
    • Hologic
    • Fast Track Diagnostics
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5247

REPORT HIGHLIGHT

RSV Diagnostics Market size was valued at USD 6,456.67 Billion in 2024, expanding at a CAGR of 5.87% from 2024 to 2032.

Respiratory Syncytial Virus (RSV) diagnostics involve detecting the presence of RSV infection in patients, primarily through respiratory samples like nasal swabs. The main diagnostic methods include nucleic acid amplification tests (NAATs) such as real-time PCR, which are highly sensitive and specific, rapid antigen detection tests (RADTs) that provide quicker but sometimes less accurate results, and viral culture, which is slower and less commonly used. Accurate detection is crucial for timely treatment and infection control, especially in infants and elderly patients vulnerable to severe RSV disease. Testing is usually performed within the early days of symptom onset to ensure reliability.

RSV Diagnostics Market- Market Dynamics

Increasing Prevalence of Respiratory Infections

The rising incidence of respiratory infections, particularly among infants, elderly individuals, and immunocompromised patients, is a major driver for the RSV diagnostics market. Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, resulting in significant hospitalizations and healthcare costs. Early and accurate diagnosis through advanced RSV diagnostic tools helps in timely treatment and reduces the spread of infection. Additionally, growing awareness among healthcare providers and improved access to diagnostic technologies further fuel market growth. These factors collectively boost demand for efficient and rapid RSV diagnostic solutions globally.

RSV Diagnostics Market- Key Insights

According to our research analyst, the global RSV Diagnostics Market is expected to develop at a CAGR of approximately 5.87% between 2024-2032.

Segmented by Product in 2024, the Kits and Assays category dominated the market.

Based on End User, the Hospitals and Clinics segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

RSV Diagnostics Market- Segmentation Analysis:

The global RSV Diagnostics Market is divided into Four categories: Product, Method, End User and Region.

By product, the RSV diagnostics market is segmented into Kits and Assays, Instruments, and Other Products. Kits and Assays include reagents and test kits used for detecting RSV antigens or nucleic acids in patient samples. Instruments refer to the devices and analyzers used to perform diagnostic tests, such as PCR machines and immunoassay readers. Other Products encompass consumables and accessories required during testing. Among these segments, Kits and Assays hold the dominant share due to their critical role in providing rapid and accurate results, which are essential for timely clinical decision-making. The convenience, ease of use, and advancements in assay technologies have driven strong adoption of kits across hospitals, clinics, and diagnostic laboratories, making this segment the largest revenue contributor in the RSV diagnostics market.

By end user, the RSV diagnostics market is segmented into Hospitals and Clinics, Clinical Laboratories, and Home Care. Hospitals and Clinics represent healthcare facilities where patients receive diagnosis and treatment directly, often handling a high volume of respiratory cases. Clinical Laboratories specialize in conducting diagnostic tests with advanced equipment and skilled personnel, serving multiple healthcare providers. Home Care involves at-home testing solutions that offer convenience and early detection outside traditional healthcare settings. Among these, Hospitals and Clinics dominate the market due to their frontline role in patient care, especially during RSV seasons when respiratory infections surge. Their need for rapid, accurate diagnostics to manage outbreaks and provide immediate treatment drives substantial demand for RSV diagnostic products, making them the largest and most influential end-user segment in the market.

RSV Diagnostics Market- Geographical Insights

Geographically, the RSV Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the RSV diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of innovative diagnostic technologies, and high healthcare spending. The region experiences a significant burden of RSV infections, especially among infants and elderly populations, increasing demand for accurate and rapid testing. Additionally, strong government support, well-established reimbursement policies, and presence of leading market players contribute to robust market growth. The growing awareness among healthcare providers and patients about the importance of early RSV diagnosis further fuels the expansion of the market in North America.

Asia Pacific is another dominant region in the RSV diagnostics market, propelled by a large patient population and rising incidence of respiratory infections. Rapid urbanization, improving healthcare facilities, and increasing investments in healthcare infrastructure enhance the adoption of RSV diagnostic solutions. Countries such as China, India, and Japan are key contributors, supported by growing government initiatives to combat infectious diseases. Additionally, increasing awareness and accessibility to diagnostic testing in both urban and rural areas are driving market growth, making Asia Pacific a critical and fast-growing segment in the global RSV diagnostics landscape.

RSV Diagnostics Market- Competitive Landscape:

The RSV diagnostics market is shaped by established diagnostics firms and innovative newcomers focusing on enhanced accuracy and rapid detection. Key players such as Abbott, Roche, Thermo Fisher, and Becton Dickinson dominate the market with a wide range of high-quality diagnostic kits, instruments, and assays. These companies invest heavily in R&D to improve test sensitivity, reduce turnaround time, and comply with stringent regulatory standards. Emerging companies are introducing novel molecular and point-of-care testing solutions, increasing competition. This dynamic fosters continuous innovation, expanding the adoption of RSV diagnostics across hospitals, clinics, and laboratories, thereby improving respiratory infection management globally.

Recent Developments:

In April 2024, Abbott launched a next-generation point-of-care molecular test for RSV and influenza, delivering faster and more accurate respiratory infection diagnosis to support better patient outcomes in diverse clinical settings.

In June 2023, BD completed the sale of its surgical instruments and laparoscopic instrumentation business to STERIS plc, streamlining its portfolio to focus on core diagnostic and medical device segments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RSV DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Biomerieux
  • Becton, Dickinson and Company (BD)
  • Abbott
  • Roche
  • Danaher
  • Thermo Fisher
  • Biocartis
  • Luminex
  • Hologic
  • Fast Track Diagnostics
  • Others

GLOBAL RSV DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Kits and Assays
  • Instruments
  • Other Products

GLOBAL RSV DIAGNOSTICS MARKET, BY METHOD - MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Rapid Antigen Detection Tests
  • Enzyme-Linked Immunosorbent Assays
  • Immunofluorescence Assays
  • Other Rapid Antigen Detection Tests
  • Chromatographic Immunoassays
  • Optical Immunoassays
  • Other Methods

GLOBAL RSV DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Clinical Laboratories
  • Home Care

GLOBAL RSV DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RSV Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RSV Diagnostics Market Snippet by Product
    • 2.1.2. RSV Diagnostics Market Snippet by Method
    • 2.1.3. RSV Diagnostics Market Snippet by End User
    • 2.1.4. RSV Diagnostics Market Snippet by Country
    • 2.1.5. RSV Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. RSV Diagnostics Key Market Trends

  • 3.1. RSV Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RSV Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RSV Diagnostics Market Opportunities
  • 3.4. RSV Diagnostics Market Future Trends

4. RSV Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RSV Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RSV Diagnostics Market Landscape

  • 6.1. RSV Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RSV Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits and Assays
    • 7.1.3. Instruments
    • 7.1.4. Other Products

8. RSV Diagnostics Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Rapid Antigen Detection Tests
      • 8.1.3.1. Enzyme-Linked Immunosorbent Assays
      • 8.1.3.2. Immunofluorescence Assays
      • 8.1.3.3. Other Rapid Antigen Detection Tests
      • 8.1.3.3.1. Chromatographic Immunoassays
      • 8.1.3.3.2. Optical Immunoassays
    • 8.1.4. Other Methods

9. RSV Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Home Care

10. RSV Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. RSV Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. RSV Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. RSV Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. RSV Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. RSV Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RSV Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biomerieux
    • 11.2.2. Becton, Dickinson and Company (BD)
    • 11.2.3. Abbott
    • 11.2.4. Roche
    • 11.2.5. Danaher
    • 11.2.6. Thermo Fisher
    • 11.2.7. Biocartis
    • 11.2.8. Luminex
    • 11.2.9. Hologic
    • 11.2.10. Fast Track Diagnostics
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us